 |
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
U.S. Centers for Disease Control and Prevention
• News Briefs
In Brief: DrugsApril 17, 2002 Pfizer will freeze the price of its AIDS drug, Viracept, for the next two years for the federal AIDS Drug Assistance Program (ADAP), according to CEO Hank McKinnell. McKinnell made the announcement at the first meeting of the President's Advisory Council on HIV/AIDS, to which he was appointed in late February. ADAP has waiting lists in 10 states and territories, and has seen its funding threatened on a national level as well. The protease inhibitor is among the best-selling medications in its class, making up more than 35 percent of protease sales in 2000. The current wholesale price for Viracept is $2.02 per tablet. Dosage is five tablets twice a day.
Adapted from:
Back to other CDC news for April 17, 2002 AIDS Policy & Law 04.12.02 This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |
E-Mail
Printable Single-Page
Glossary
Share
